March 7, 2018 / 9:39 PM / in 7 months

BRIEF-Xenon Pharma, Teva Pharma Terminate Development & License Agreement

March 7 (Reuters) - Xenon Pharmaceuticals Inc:

* XENON PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* XENON PHARMA - CO, TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA CANADA, ENTERED DEAL TO MUTUALLY TERMINATE DEC 7, 2012 DEVELOPMENT & LICENSE AGREEMENT

* XENON PHARMA - AS PER TERMINATION AGREEMENT, TEVA AGREED TO TRANSFER AND ASSIGN 1 MILLION SHARES OF CO HELD BY TEVA CANADA LTD TO CO FOR CANCELLATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below